3.0.0 3696 2023-01-13T04:50:15Z 2023-01-13T04:50:15Z House H HR 2005-09-08 109 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2005-09-19T19:25:56Z Referred to 2005-09-08T14:01:10Z 2005-09-19 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2005-09-08 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-09-08 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-09-08 Introduced in House IntroReferral 1000 9 Library of Congress B000944 Rep. Brown, Sherrod [D-OH-13] Sherrod Brown D OH 13 N B000420 Rep. Berry, Marion [D-AR-1] MARION BERRY D AR 1 2005-09-27 False H000627 Rep. Hinchey, Maurice D. [D-NY-22] MAURICE HINCHEY D NY D. 22 2005-09-29 False Health Administrative procedure Administrative remedies Commerce Congress Congressional investigations Congressional reporting requirements Cost effectiveness Department of Health and Human Services Drug advertising Drugs Government Operations and Politics Government publicity Health education Labeling Law Medical supplies Public service advertising Health 00 2005-09-08 Introduced in House 2005-11-25T14:06:20Z Medical Advertising Reform Act - Amends the Federal Food, Drug, and Cosmetic Act to require prior approval by the Secretary of Health and Human Services of consumer-directed advertising for prescription drugs and restricted medical devices.

Prohibits drugs advertising for a two-year period after approval of a new prescription drug. Allows the Secretary to extend such period as necessary to protect the public health. Deems prescription drugs to be misbranded for failure to comply with the advertising prohibition during such period.

Requires the Secretary, acting through the Commissioner of Food and Drugs, to report to Congress regarding a proposal to include on the labeling and advertisements for prescription drugs information on the comparative effectiveness and comparative cost-effectiveness of a drug to other drugs in the same class.

Directs the Comptroller General to study the impact of consumer-directed advertising on restricted device utilization and spending.

Requires the Secretary to maintain a toll-free number to provide the public with objective information on health conditions and treatments.

]]> Medical Advertising Reform Act Display Title Medical Advertising Reform Act Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to require prior approval by the Food and Drug Administration of advertisements for prescription drugs and restricted medical devices, and for other purposes. Introduced in House IH Short Titles as Introduced Medical Advertising Reform Act Introduced in House 2005-09-08T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109hr3696ih/xml/BILLS-109hr3696ih.xml 2005-09-19 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.